Sinopharm
1099.HK
#2582
Rank
โ‚น673.30 B
Marketcap
โ‚น215.76
Share price
-1.35%
Change (1 day)
4.82%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2025: โ‚น235.30 Billion

According to Sinopharm's latest financial reports the company's current earnings are โ‚น82.21 Billion. In 2025 the company made an earning of โ‚น235.30 Billion, an increase over its 2024 earnings that were of โ‚น220.75 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2025

Annual earnings

Year Earnings Change
2025โ‚น235.30 B6.59%
2024โ‚น220.75 B-27.86%
2023โ‚น306.01 B-0.73%
2022โ‚น308.26 B-1.72%
2021โ‚น313.64 B11.7%
2020โ‚น280.78 B18.44%
2019โ‚น237.06 B10.85%
2018โ‚น213.86 B3.05%
2017โ‚น207.53 B36.48%
2016โ‚น152.06 B7.11%
2015โ‚น141.97 B12.38%
2014โ‚น126.33 B25.05%
2013โ‚น101.03 B22.54%
2012โ‚น82.45 B35.43%
2011โ‚น60.87 B52.24%
2010โ‚น39.98 B30.99%
2009โ‚น30.52 B60.59%
2008โ‚น19.00 B48.29%
2007โ‚น12.81 B123.29%
2006โ‚น5.74 B